JPRN-UMIN000026828
Completed
未知
A pilot study to evaluate the effect of colchicine treatment on NSAID-induced small intestinal damage - Effect of colchicine on NSAID-induced small intestinal damage (a pilot study)
Department of Gastroenterology, Osaka City University Graduate School of Medicine0 sites8 target enrollmentApril 3, 2017
ConditionsSAID-induced small intestinal damage
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- SAID-induced small intestinal damage
- Sponsor
- Department of Gastroenterology, Osaka City University Graduate School of Medicine
- Enrollment
- 8
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Malignant tumor or severe systemic disease (CNS disase or psychiatric disease) 2\) Crohns disease, intestinal tuberculosis, or known gastrointestinal stricture 3\) Unable to swallow the video capsule 4\) Pacemaker 5\) Concomitant use of antibiotics 6\) Severe liver disease 7\) Severe renal disease 8\) Hypersensitivity for colchicine 9\) Pregnant or lactating women 10\) Active small bowel bleeding (Patients with endoscopic hemostasis or intravascular embolization can be enrolled.) 11\) Inadequate judged by PI
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 2
Colchichine use for preventing COVID infection in haemodialysis patientsCTRI/2020/08/027102Dr Krishna Kishore C
Recruiting
Phase 2
Effect of Colchicine on aphthous ulceration.Aphthous.Recurrent oral aphthaeK12.0IRCT20160920029889N4Mazandaran University of Medical Sciences10
Recruiting
Phase 3
Effect of Colchicine in patient presenting with non ST-elevation myocardial infarctioIRCT20190601043780N1Mashhad University of Medical Sciences140
Recruiting
Phase 3
Evaluation of colchicine in treatment of coronavirusPulmonary infection of COVD19.Coronavirus infection, unspecifiedB34.2IRCT20200418047126N1Ardabil University of Medical Sciences100
Completed
Phase 2
Colchicine in combination with infliximb compared with infliximb in the treatment of patients with Covidian 19COVID-19.COVID-19, virus identifiedU07.1IRCT20200325046854N2Iran University of Medical Sciences70